NEW YORK (Reuters) -Health and wellness companies are embracing weight-loss drugs and building offerings around them in an ...

A conference poster presented at the European Congress on Obesity (ECO) looks at weight loss drugs (GLP-1s) and reduced alcohol intake. Prof Kevin McConway, Emeritus Professor of Applied Statistics, ...

The request follows a similar move by Eli Lilly, which has asked for ... turning to unapproved versions of GLP-1 drugs as an option for weight loss, saying: "This can be risky for patients ...